Differential Diagnosis and Work-Up for Diffuse Patchy Reticulonodular Pattern
The most critical first step is obtaining high-resolution CT (HRCT) of the chest, as plain radiography showing a reticulonodular pattern is nonspecific and has limited diagnostic sensitivity—HRCT is essential to characterize the specific pattern and guide subsequent management 1, 2.
Key Differential Diagnoses by Pattern
The reticulonodular pattern encompasses multiple distinct entities that HRCT will help differentiate:
Interstitial Lung Diseases (Most Common)
Idiopathic Interstitial Pneumonias:
- Usual Interstitial Pneumonia (UIP)/IPF: Heterogeneous peripheral and basal predominant fibrosis with honeycombing, subpleural distribution 3
- Nonspecific Interstitial Pneumonia (NSIP): Bilateral symmetric ground-glass opacities or consolidation, lower zone predominant, homogeneous appearance with better prognosis than UIP (most improve with corticosteroids, 15-20% mortality at 5 years) 3
- Organizing Pneumonia (OP): Patchy consolidation in peripheral/peribronchovascular distribution, often migratory, excellent response to corticosteroids 4
- Desquamative Interstitial Pneumonia (DIP): Ground-glass opacity in middle/lower zones, primarily in smokers, 70% survival at 10 years 3
- Respiratory Bronchiolitis-ILD (RBILD): Fine reticular/nodular opacities in smokers, bronchiolocentric distribution, better prognosis than IPF 3
Hypersensitivity Pneumonitis:
- Nonfibrotic HP: Profuse poorly-defined centrilobular ground-glass nodules, mosaic attenuation with three-density pattern, air trapping 5, 6, 5
- Fibrotic HP: Bronchiolocentric fibrosis pattern, can mimic UIP but with different distribution (often mid-lung or upper lobe predominant) 5, 6
Acute/Subacute Processes
- Acute Interstitial Pneumonia (AIP): Rapidly progressive (days to weeks), bilateral ground-glass opacities and consolidation, 50% mortality, requires exclusion of known ARDS causes 3, 4
- Drug-Related Pneumonitis: Various patterns (NSIP, OP, HP-like, DAD), requires medication history review 7
Other Important Considerations
- Connective tissue disease-related ILD: Similar patterns to idiopathic forms but with systemic features 3, 5
- Sarcoidosis: Perilymphatic nodular distribution, hilar/mediastinal lymphadenopathy 5
- Infection: Particularly viral, atypical bacterial, or fungal (bronchocentric granulomatosis can mimic malignancy) 8, 9
Recommended Diagnostic Algorithm
Step 1: HRCT Chest (Immediate Priority)
Obtain HRCT with:
- Thin-section (1-1.5mm) images
- Supine inspiratory images (mandatory)
- Expiratory images (essential for air trapping assessment in HP)
- Prone images (helpful to distinguish dependent atelectasis from true disease) 1
HRCT will categorize the pattern into:
- Reticular (lines/networks)
- Nodular (centrilobular vs. perilymphatic vs. random)
- Ground-glass opacity
- Consolidation
- Cystic changes
- Distribution (upper vs. lower, peripheral vs. central, bronchiolocentric)
Step 2: Clinical Context Assessment
Essential history elements:
- Tempo: Acute (days-weeks) vs. subacute (weeks-months) vs. chronic (months-years) 10
- Smoking history: DIP and RBILD occur almost exclusively in smokers 3
- Occupational/environmental exposures: Organic antigens for HP (birds, mold, hot tubs) 5, 6
- Medication history: Chemotherapy agents, immunotherapy, molecular targeted agents 7
- Systemic symptoms: Connective tissue disease features, fever, weight loss
- Age and sex: DIP/RBILD typically 40s-50s; lymphangioleiomyomatosis in women of childbearing age
Step 3: Initial Laboratory and Physiologic Testing
- Pulmonary function tests: Restrictive pattern with reduced DLCO typical of ILD 3
- Arterial blood gas: Assess hypoxemia severity
- Autoimmune serology: ANA, RF, anti-CCP, myositis panel, antisynthetase antibodies
- Hypersensitivity panel: Serum precipitins if HP suspected (though limited sensitivity/specificity) 6
Step 4: Bronchoscopy with BAL
Indications:
- Suspected HP (lymphocyte count >20-40% supports diagnosis) 5
- Rule out infection or malignancy
- When combined with transbronchial biopsy, increases diagnostic yield particularly in HP 5
BAL findings:
- Lymphocytosis: HP, NSIP, organizing pneumonia
- Eosinophilia: Drug reaction, eosinophilic pneumonia
- Neutrophilia: UIP/IPF, acute processes
Step 5: Tissue Diagnosis (When Needed)
Surgical lung biopsy indications:
- HRCT pattern indeterminate or atypical
- Discordance between clinical and radiologic findings
- Before initiating immunosuppression in unclear cases
- Multiple lobe sampling preferred to capture heterogeneity 3
Transbronchial biopsy:
- May be diagnostic in HP (40% yield showing granulomas/giant cells with inflammatory bronchiolitis) 5
- Limited role in UIP/IPF diagnosis
- Useful when combined with BAL
Step 6: Multidisciplinary Discussion
Integration of clinical, radiologic, and pathologic data through multidisciplinary discussion (pulmonologist, radiologist, pathologist) improves diagnostic accuracy and confidence 1.
Critical Pitfalls to Avoid
Do not rely on chest radiography alone—the "reticulonodular pattern" is too nonspecific and misses early/subtle disease 2, 11
Do not assume UIP/IPF without excluding HP—fibrotic HP can present with UIP pattern on HRCT but has different treatment and prognosis; look for bronchiolocentric features, three-density pattern, and exposure history 5, 6
Do not overlook smoking history—DIP and RBILD require smoking exposure and have much better prognosis than IPF 3
Do not skip expiratory HRCT images—air trapping is critical for diagnosing HP and small airways disease 6, 1
Do not biopsy without HRCT—HRCT guides biopsy location and may obviate need for biopsy in classic UIP pattern 1
Do not miss drug-induced disease—always review complete medication history including recent additions 7
In acute presentations (days to weeks), aggressively exclude infection and consider AIP/acute exacerbation—these carry 50% mortality and require urgent intervention 3, 4